FDA — authorised 9 December 1983
- Application: NDA018685
- Marketing authorisation holder: CHATTEM SANOFI
- Local brand name: GAVISCON
- Indication: TABLET, CHEWABLE — ORAL
- Status: approved
🇺🇸 Gaviscon in United States
FDA authorised Gaviscon on 9 December 1983
Marketing authorisations
FDA
- Status: approved
Gaviscon in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United States
Frequently asked questions
Is Gaviscon approved in United States?
Yes. FDA authorised it on 9 December 1983; FDA has authorised it.
Who is the marketing authorisation holder for Gaviscon in United States?
CHATTEM SANOFI holds the US marketing authorisation.